[1] 杨娜.螺旋藻的开发与利用[J].海洋药物, 1986, (3) ∶54-58.
|
[2]梁江明, 吴开国, 磨传真, 等.螺旋藻对缺铁性贫血的恢复实验[J].营养学报, 1994, 16∶386-390.
|
[3] 张吉德, 汪自源.我国海洋中药的发展和临床应用[J].中国海洋药物杂志, 1990, 34 (2) ∶21-23.
|
[4]郑刚, 郝军, 贾钢锐, 等.褐藻胶对大鼠实验性肝纤维化的防治作用[J].中国海洋药物杂志, 1997, 61 (1) ∶30-32.
|
[5]MartinGR , KleinmanHK .Theextracellularmatrixindevelopmentandindisease[J].SeminLiverDis, 1985, 5 (2) ∶147-56.
|
[6] ThorntonSC .Interactionofimmuneandconnectivetissuecellthe.Theeffectoflymphokinesandmonokinesonfibroblasegrowth[J].JleukocBi ol, 1990, 47 (4) ∶312-20
|
[1] | Xiaofei SHANG, Xiuhui LI. Advances in the experimental research on traditional Chinese medicine against liver fibrosis[J]. Journal of Clinical Hepatology, 2023, 39(2): 249-259. doi: 10.3969/j.issn.1001-5256.2023.02.001 |
[2] | Ding Jie, Wang Liang, Li Juan, Kong Yin, Zhao Rui, He JingJing, Li GuangMing, Wang JuanXia, Zhang LingYi. Changes in serum asymmetric dimethylarginine levels in progression of liver inflammation in an experimental rat model of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2016, 32(1): 148-151. doi: 10.3969/j.issn.1001-5256.2016.01.029 |
[3] | Zhu JinZhao, Rao JunWei, Lu: Yong, Li Huan. Changes in distribution of cholinergic and nitrergic nerves in antrum of rats with liver failure[J]. Journal of Clinical Hepatology, 2014, 30(10): 1023-1026. doi: 10.3969/j.issn.1001-5256.2014.10.012 |
[4] | Wang WeiZhen, Meng MingHui, Kong Li, Zhang QingShan, Zhao SuXian, Nan YueMin. Role of Jak /Stat pathway in CCl4- induced rat liver fibrosis model and molecular action mechanism of Fuzheng Huayu recipe in treatment of liver fibrosis[J]. Journal of Clinical Hepatology, 2014, 30(4): 344-348. doi: 10.3969/j.issn.1001-5256.2014.04.014 |
[5] | Nong XiTing, Huang Hua, Qin Rong, Lu MingLiang. The Changes in substance P in jejunum of fatty liver[J]. Journal of Clinical Hepatology, 2010, 26(1): 33-35. |
[7] | Hu TaiHong, Jiang XiangHu, Jiang YueMing, Zhou Min, Xu Min, Zhu Rui, Yang Ling. Expression of NF-κB and ERK-1mRNA in rat with liver fibrosis[J]. Journal of Clinical Hepatology, 2009, 25(1): 23-25. |
[10] | Wang Yan, Li BingShun, Wang JianBin. Study about ultrasonic and fibrosis parameters with diagnose of hepatic fibrosis[J]. Journal of Clinical Hepatology, 2008, 24(1): 31-33. |
[11] | Song MinNing, Chen Fu, Song YuNa, Xie ZeJin. The influence of 5-hydroxytryptamine on rat with hepatic encephalopathy.[J]. Journal of Clinical Hepatology, 2008, 24(2): 88-91. |
[12] | Xing LingXiang, He YongWen. Experiment study on nonalcoholic fatty liver model induced by injection of oxytetracycline intraperitoneally in rats[J]. Journal of Clinical Hepatology, 2007, 23(1): 29-31. |
[13] | Qin Gang, Shi GuangFeng, Li Qian, Lu Qing, Chen Shu. Inhibitory effects of UDCA on porcine serum-induced rat liver fibrosis[J]. Journal of Clinical Hepatology, 2007, 23(4): 263-265. |
[15] | Zhao XinYan, Wang BaoEn, Wang TaiLing, Jia JiDong, Ma XueMei. Comparative study of the effect of two different herbal compounds on CCl4 induced liver fibrosis in rats.[J]. Journal of Clinical Hepatology, 2005, 21(1): 21-24. |
[17] | Kong Li, Li BingShun, Ren ZhongXuan, Hu YunLong, Liu JinXing. The study of inhibitory effect of IFN-α therapy for hepatic fibrosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2002, 18(6): 356-358. |
[18] | Wang YingKai, Wang Dan, Tang TongYu. Experimental and clinical study of liver fibrosis therapy with chinese herbal of turtle'crust[J]. Journal of Clinical Hepatology, 2002, 18(4): 253-254. |
[19] | Yin ChengHong, Ma Hong, Ma XueMei, Liu TianHui, Jia JiDong, Wang BaoEn. The effect of compound 861 on MMP2mRNA expression in liver fibrosis induced by bile Duct occlusion in rats[J]. Journal of Clinical Hepatology, 2002, 18(4): 248-250. |